Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

Warner Chilcott



) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.5%. By the end of trading, Warner Chilcott rose $0.16 (1.2%) to $13.79 on light volume. Throughout the day, 3,107,309 shares of Warner Chilcott exchanged hands as compared to its average daily volume of 4,732,400 shares. The stock ranged in a price between $13.32-$13.87 after having opened the day at $13.64 as compared to the previous trading day's close of $13.63. Other companies within the Health Care sector that increased today were:

AdCare Health Systems



), up 36.7%,

Catalyst Pharmaceutical Partners



), up 19.1%,




), up 16.2% and

Aoxing Pharmaceutical Company



), up 15.9%.

  • EXCLUSIVE OFFER: Jim Cramer's Protege, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Warner Chilcott Public Limited Company, a specialty pharmaceutical company, engages in the development, manufacture, promotion, and franchise of branded pharmaceutical products focusing on the women's healthcare, gastroenterology, urology, and dermatology markets. Warner Chilcott has a market cap of $3.5 billion and is part of the drugs industry. The company has a P/E ratio of 13.3, below the S&P 500 P/E ratio of 17.7. Shares are down 2.1% year to date as of the close of trading on Wednesday.

TheStreet Ratings rates Warner Chilcott as a


. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, expanding profit margins and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and weak operating cash flow.

On the negative front,

Cardium Therapeutics



), down 16.9%,

CAS Medical Systems



), down 12.4%,

Exact Sciences Corporation



), down 11.4% and

Sinovac Biotech



), down 9.9% , were all laggards within the health care sector with

Celgene Corporation



) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care




Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.